Royal Bank of Canada’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Buy |
|
|||||
|
2025
Q1 | $35K | Sell |
|
|||||
|
2024
Q4 | $40K | Sell |
|
|||||
|
2024
Q3 | $79K | Buy |
|
|||||
|
2024
Q2 | $88K | Sell |
|
|||||
|
2024
Q1 | $174K | Sell |
|
|||||
|
2023
Q4 | $309K | Buy |
|
|||||
|
2023
Q3 | $239K | Buy |
|
|||||
|
2023
Q2 | $168K | Buy |
|
|||||
|
2023
Q1 | $147K | Buy |
|
|||||
|
2022
Q4 | $132K | Buy |
|
|||||
|
2022
Q3 | $124K | Hold |
|
|||||
|
2022
Q2 | $122K | Sell |
|
|||||
|
2022
Q1 | $139K | Sell |
|
|||||
|
2021
Q4 | $168K | Sell |
|
|||||
|
2021
Q3 | $315K | Buy |
|
|||||
|
2021
Q2 | $281K | Sell |
|
|||||
|
2021
Q1 | $2.01M | Buy |
|
|||||
|
2020
Q4 | $1.75M | Sell |
|
|||||
|
2020
Q3 | $1.97M | Sell |
|
|||||
|
2020
Q2 | $2.67M | Buy |
|
|||||
|
2020
Q1 | $1.8M | Sell |
|
|||||
|
2019
Q4 | $3.41M | Buy |
|
|||||
|
2019
Q3 | $467K | Buy |
|
|||||
|
2019
Q2 | $645K | Buy |
|
|||||
|
2019
Q1 | $444K | Buy |
|
|||||
|
2018
Q4 | $283K | Sell |
|
|||||
|
2018
Q3 | $354K | Buy |
|
|||||
|
2018
Q2 | $301K | Buy |
|
|||||
|
2018
Q1 | $251K | Buy |
|
|||||
|
2017
Q4 | $140K | Buy |
|
|||||
|
2017
Q3 | $55K | Buy |
|